Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3629-3635

  Delgado, Mario ^a,b   Leceta, Javier ^b   Gomariz, Rosa P ^b   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; HEMOCYANIN; IMMUNOGLOBULIN ISOTYPES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MITOGENS; MOLLUSCA; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; TH1 CELLS; TH2 CELLS; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033214997     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. O'Garra, A. O. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
2. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
3. Lenschow, D. J., A. I. Sperling, M. P. Cooke, G. Freeman, L. Rhee, D. C. Decker, G. Gray, L. M. Nadler, C. C. Goodnow, and J. A. Bluestone. 1994. Differential up-regulation of the B7.1 and B7.2 costimulatory molecules following immunoglobulin receptor engagement by antigen. J. Immunol. 153:1990.
4. Creery, W. D., F. Diaz-Mitoma, L. Filion, and A. Kumar. 1996. Differential modulation of B7.1 and B7.2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur. J. Immunol. 26:1273.
5. + T cells to effector IL-4-producing T helper cells. Immunol. Res. 14:176.
6. Salomon, B., and J. A. Bluestone. 1998. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161:5138.
7. Manickasingham, S., S. M. Anderton, C. Burkhart, and D. C. Wraith. 1998. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naïve T cells in vitro. J. Immunol. 161:3827.
8. Harris, N. L., R. J. Peach, and F. Ronchese. 1999. CTLA4-Ig inhibits optimal Th2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. Eur. J. Immunol. 29:311.
9. Leceta, J., C. Martinez, M. Delgado, E. Garrido, and R. P. Gomariz. 1996. Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune response. Adv. Neuroimmunol. 6:29.
10. Bellinger, D. L., D. Lorton, S. Brouxhon, S. Felten, and D. L. Felten. 1996. The significance of vasoactive intestinal peptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6:5.
11. Ganea, D. 1996. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:61.
12. De la Fuenle, M., M. Delgado, and R. P. Gomariz. 1996. VIP modulation of immune cell functions. Adv. Neuroimmunol. 6:75.
13. O'Dorisio, M. S. 1987. Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systems. Fed. Proc. 46:192.
14. Ottaway, C. A., and G. R. Greenberg. 1984. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J. Immunol. 132:417.
15. Calvo, J. R., D. Pozo, and J. M. Guerrero. 1996. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent systems. Adv. Neuroimmunol. 6:39.
16. Delgado, M., E. J. Munoz-Elias, C. Martinez, R. P. Gomariz, and D. Ganea. 1999. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP38) modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann. NY Acad. Sci. In press.
17. + lymphocytes by inhibiting IL-12 production. J. Immunol. 160:2231.
18. Desmedt, M., P. Rottiers, H. Dooms, W. Fiers, and J. Grooten. 1998. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J. Immunol. 160:5300.
19. Wilder, J. A., C. Y. Koh, and D. Yuan. 1996. The role of NK cells during in vivo antigen-specific antibody responses. J. Immunol. 156:146.
20. Russell, M. W., T. A. Brown, J. Radl, J. J. Haajraan, and J. Mestecky. 1986. Assay of human subclass antibodies in serum and secretions by means of monoclonal antibodies. J. Immunol. Methods 87:87.
21. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T-cells. Nature 334:255.
22. Martinez, C., M. Delgado, R. P. Gomariz, and D. Ganea. 1996. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:4128.
23. Wang, H-Y., Z. Xin., H. Tang, and D. Ganea. 1996. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J. Immunol. 156:3243.
24. Tang, H., A. Welton, and D. Ganea. 1995. Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553. J. Interferon Cytokine Res. 15:993.
25. Esser, C., and A. Radbruch. 1989. Rapid induction of transcription of unrearranged SγI switch regions in activated murine B cells by IL-4. EMBO J. 8:483.
26. Snapper, C. M., and W. E. Paul. 1987. B cell stimulatory factor-1 (interleukin 4) prepares resting B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide. J. Immunol. 139:10.
27. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulating factor-1 reciprocally regulate Ig-isotype production. Science 236:944.
28. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
29. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7.1 and B7.2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
30. Keany-Myers, A. M., W. C. Gause, F. D. Finkelman, X.-D. Xhou, and M. Wills-Karp. 1998. Development of murine allergic asthma is dependent upon B7-2 costimulation. J. Immunol. 160:1036.
31. Taylor-Robinson, A. W., and E. C. Smith. 1999. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T cell costimulatory pathway. Immunology 96:498.
32. Larche, M., S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson. 1998. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J. Immunol. 161:6375.
33. Hernandez, H. J., A. H. Sharpe, and M. J. Stadecker. 1999. Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation. J. Immunol. 162:2884.
34. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
35. Delgado, M., E. J. Munoz-Elias, R. P. Gomariz, and D. Ganea. 1999. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages: subsequent effect on IFN-γ synthesis by T cells. J. Neuroimmunol. 96:167.
36. Delgado, M., W. Sun, J. Leceta, and D. Ganea. 1999. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J. Immunol. In press.